A recent pancreatic cancer study showed that PD-L1+ T cells exerted tumor-promoting tolerance in 3 ways: PD-L1+ T cells could prevent activation, reduce Th1 polarization and promote Th17 differentiation (31). This evidence concerns the gene CD274 and familial pancreatic carcinoma.